Article · 29 Aug 2026
Conference abstract
Mucosal immunisation against respiratory tract infections
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Induction of mucosal immune responses best occur through priming of mucosal associated lymphoid aggregates that selectively sample the milieu bathing the mucosal surfaces. Despite considerable research and the advantages of mucosal immunisation, few oral vaccines are routinely available for use today with the results of many oral vaccine trials being variable and suboptimal at best. Over the last three decades our group has undertaken extensive studies in animal models and in human trials to develop an effective oral vaccine against respiratory tract infections caused by non-typeable Haemophilus influenzae (NTHi) and Pseudomonas aeruginosa. Human studies have focused on subjects with chronic obstructive pulmonary disease (COPD) and bronchiectasis. Animal studies of acute and chronic respiratory infection models have provided proof of concept pre-clinical data and significant knowledge about the immunological mechanisms induced by mucosal immunisation. Oral immunisation of subjects with COPD against NTHi has resulted in a significant reduction in acute exacerbations, hospitalisation and antibiotic prescriptions. For P aeruginosa, administration of an oral whole killed cell vaccine reduced number of P. aeruginosa cultured from sputum and induced a functional antibody response against the vaccine strain in subjects with bronchiectasis. These studies clearly demonstrate that oral immunisation should be considered as an effective route of vaccination for infections of the respiratory tract.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Allan W Cripps”
